Neuroimmunology Overview

Principles

Definition

Neuroimmunology is the interdisciplinary field of study that investigates the complex interactions and bidirectional communication between the nervous system and the immune system. This research is fundamental to understanding the mechanisms underlying health, disease pathogenesis, and therapeutic interventions at the interface of these two critical physiological systems.

Ontological type

Core Mechanisms

Disease Pathogenesis

Therapeutic Strategies

Key developments

Key Figures

Immunohistochemical Mapping era

W. I. McDonald [1] is highlighted for his work across University College London [3] and Tulane University [4] during the Immunohistochemical Mapping era (1957–1985). His 1983 paper, New diagnostic criteria for multiple sclerosis: Guidelines for research protocols [7], contributed to standardizing diagnostic criteria and research protocols, a crucial step enabling comparability across studies and translation of mapping insights into clinical neuroimmunology. George C. Ebers [2] linked his work with Rockefeller University [5] and the University of British Columbia [6] during this era. Building on the MS criteria framework [7], Ebers [2] helped advance standardization that enabled cross-study comparability and strengthened the clinical neuroimmunology research that underpinned immunohistochemical mapping.

Microglia-Centric Neuroinflammation era

Alan J. Thompson [1] is a prominent figure in the microglia-centered neuroinflammation era, with affiliations to Yale University [3] and the Medical University of Vienna [4]. His key contributions in this era include shaping diagnostic criteria for multiple sclerosis through the guidelines published in 2001, notably the paper "Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis" [6], which standardized case definitions and enabled comparability across studies. Hans-Peter Hartung [2] is likewise a central figure, with ties to the University of Pennsylvania [5] and the Medical University of Vienna [4] during this era. His key contributions center on advancing MS diagnostic consensus via the 2001 guidelines paper [6], which helped translate neuroinflammatory research into clinical practice.

Microglial Heterogeneity and Remodeling era

Ted M. Dawson [1] is a central figure in neuroimmunology during the Microglial Heterogeneity and Remodeling era (2007-2023), with affiliations at Harvard University [3] and the Forest Institute [4]. His key contributions in this era include the insights from the 2017 paper Neurotoxic reactive astrocytes are induced by activated microglia [6] and the 2017 paper T cells from patients with Parkinson’s disease recognize α-synuclein peptides [7], which together show that activated microglia shape astrocyte reactivity and adaptive immunity, reframing microglial states as therapeutic targets. Valina L. Dawson [2] is a central collaborator in this field, with affiliations at Forest Institute [4] and Johns Hopkins University [5] during this era. Her contributions in these 2017 papers Neurotoxic reactive astrocytes are induced by activated microglia [6] and T cells from patients with Parkinson’s disease recognize α-synuclein peptides [7] helped establish how microglia–astrocyte crosstalk and peripheral immunity drive disease-associated microglial remodeling, underscoring the need to modulate microglial heterogeneity rather than suppress inflammation.